June 11, 2025

Does Paracetamol Block Peripheral Pain?

A newly published study showed that a metabolite of paracetamol can directly block sodium channels in peripheral pain-sensing neurons, helping reduce pain without acting on the brain.

Conexiant

June 06, 2025

FDA Monthly Round-up: Key May Updates

May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.

Conexiant

June 04, 2025

Medical Oddities: Legumes Over Lipids?

From ticklish brains to bean-powered cholesterol drops, here’s what made the medical rounds weirdly wonderful this week.

Conexiant

May 29, 2025

Sleep Medication Use Over Time Worsens Hearing

A decades-long study found that adults who increased their use of sleep medications over time experienced worse hearing in late life, with the strongest associations seen in those reporting sleep disruptions.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 27, 2025

Rizatriptan Shows No Rapid Relief for Vertigo

A randomized trial found that rizatriptan 10 mg did not significantly reduce vertigo or dizziness within 1 hour during vestibular migraine attacks, though some symptom improvements were seen at 24 hours.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 19, 2025

Ubrogepant Reduces Migraine Symptoms Before Headache

In a randomized trial of nearly 500 patients, ubrogepant reduced early migraine symptoms like fatigue, neck pain, and cognitive fog when taken before headache onset.

Conexiant

April 28, 2025

One Third Report HPPD After Psychedelics

Delusional ideation was found to be reduced one month after psychedelic use, researchers reported in a prospective cohort of 654 participants.

Conexiant